174 related articles for article (PubMed ID: 38402145)
1. Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection.
Zhang F; Ni L; Zhang Z; Luo X; Wang X; Zhou W; Chen J; Liu J; Qu Y; Liu K; Guo L
Microb Cell Fact; 2024 Feb; 23(1):61. PubMed ID: 38402145
[TBL] [Abstract][Full Text] [Related]
2. Oral Immunization With a M Cell-Targeting Recombinant
Guo L; Zhang F; Wang S; Li R; Zhang L; Zhang Z; Yin R; Liu H; Liu K
Front Immunol; 2022; 13():918160. PubMed ID: 35911756
[TBL] [Abstract][Full Text] [Related]
3. An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins.
Zhang F; Shi T; Zhang Z; Wang S; Liu J; Li Y; Wang X; Liu K; Guo L
Appl Microbiol Biotechnol; 2024 Feb; 108(1):231. PubMed ID: 38396242
[TBL] [Abstract][Full Text] [Related]
4. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
7. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
8. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
9. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
11. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
12. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
13. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
[TBL] [Abstract][Full Text] [Related]
14. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
Lee MH; Roussel Y; Wilks M; Tabaqchali S
Vaccine; 2001 Jul; 19(28-29):3927-35. PubMed ID: 11427267
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice.
Zhang R; Wang C; Cheng W; Duan G; Shi Q; Chen S; Fan Q
Biotechnol Lett; 2018 Mar; 40(3):585-590. PubMed ID: 29299716
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
18. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
Xie W; Zhao W; Zou Z; Kong L; Yang L
Helicobacter; 2021 Jun; 26(3):e12807. PubMed ID: 33847026
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
20. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
